1. Shanson, D. C., Akash, S., Harris, M., Tadayon, M. Erythromycin stearate 1.5 g for the oral prophylaxis of streptococcal bacteraemia in patients undergoing dental extraction: efficacy and tolerance. Journal of Antimicrobial Chemotherapy 1985, 15: 83–90.
2. Funck-Brentano, C., Pessayre, D., Benhamou, J. P. Hepatitis due to different derivatives of erythromycin. Gastroenterologie Clinique and Biologique 1983, 7: 362–369.
3. Qin, X. Y., Pilot, M. A., Thompson, H. H., Maskell, J. P. Comparison of the side-effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs. Journal of Antimicrobial Chemotherapy 1986, 18: 747–756.
4. Puri, S. K., Lassman, H. B., Ho, I., Sabo, R., Barry, A. Safety, tolerance and multiple oral doses of RU28965 (a new macrolide antibiotic) in healthy man. In: Butzler, J. P., Kabayashi, N. (ed.): Macrolides. Excerpta Medica, Amsterdam, 1986, p. 128–137.
5. Ferandes, B. P., Bailer, R., Swanson, R., Hanson, C., McDonald, E., Ramer, N., Hardy, D., Shipkowitz, N., Bower, R., Gade, E. In vitro and in vivo evaluation of A-56268 (TE-031) a new macrolide. Antimicrobial Agents and Chemotherapy 1986, 30: 865–873.